WebMar 30, 2024 · Inhibrx, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of biologic therapeutic candidates in oncology and orphan diseases. Its clinical pipeline includes therapeutic candidates, such as INBRX-101, INBRX-109, INBRX-105 and INBRX-106. INBRX-101 is an engineered recombinant human alpha-1 ... WebThe Inhibrx Inc stock price fell by -1.21% on the last day (Thursday, 6th Apr 2024) from $17.36 to $17.15.It has now fallen 4 days in a row. During the last trading day the stock fluctuated 7.10% from a day low at $16.75 to a day high of $17.94.The price has fallen in 7 of the last 10 days and is down by -17.35% for this period. Volume has increased on the last …
Inhibrx, Inc. Common Stock (INBX) - Nasdaq
WebApr 7, 2024 · Finance Inhibrx Inc. (NASDAQ:INBX) price on Thursday, April 06, fall -1.21% below its previous day’s close as a downside momentum from buyers pushed the stock’s … WebShares of Inhibrx ( NASDAQ: INBX) jumped up in early-morning trading on Tuesday as, following its discussions with the U.S. Food and Drug Administration (FDA), the clinical-stage biopharmaceutical company announced that there was potential to pursue the accelerated approval of INBRX-101, an optimized recombinant human AAT-Fc fusion … shara fryer wikipedia
INBX Stock Price Inhibrx Inc. Stock Quote (U.S.: …
WebStock analysis for Inhibrx Inc (INBX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebINBX Stock Latest News. Press Releases Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results. 1M ago. INBX. The Fly Inhibrx reports Q4 EPS (95c), consensus (79c) 1M ago. INBX. The Fly Inhibrx, NorthStar Medical Radioisotopes enter collaboration to treat cancer. 3M ago. Web2 days ago · Inhibrx, Inc. (INBX) Stock Price, Quote & News - Stock Analysis No 1Y chart data available About INBX Inhibrx, Inc., a clinical-stage biotechnology company, focuses … shara fryer houston